International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, Bernhard Mlecnik, Florence Marliot, +95

The Lancet

Prognostic BiomarkersOncologyInternational ValidationMedicineImmunology +10

In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

Franck Pagès, Amos Kirilovsky, Bernhard Mlecnik, +12

Journal of Clinical Oncology

Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

Maria-Gabriela Aniței, Guy Zeitoun, Bernhard Mlecnik, +15

Clinical Cancer Research

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients

Marc Van den Eynde, Bernhard Mlecnik, Gabriela Bindea, +23

Cancer Cell

Immune EvasionCancer ImmunosurveillanceMedicineImmunologyBiological Microenvironments +6

Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival

Bernhard Mlecnik, Marc Van den Eynde, Gabriela Bindea, +20

JNCI Journal of the National Cancer Institute

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer

Bernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, +88

Journal of Clinical Oncology

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

María Paula Roberti, Satoru Yonekura, Connie P.M. Duong, +42

Nature Medicine

Mucosal ImmunologyMedicineProximal Colon CancerImmunologyGastroenterology +9

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

Franck Pagès, Thierry André, Déwi Vernerey, +17

Annals of Oncology

MedicineCancer ManagementImmunologyColorectal CancerPathology +5

The high frequency of complement factor H related <i>CFHR1</i> gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome

Marie‐Agnès Dragon‐Durey, Caroline Blanc, Florence Marliot, +5

Journal of Medical Genetics

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde, +29

Clinical Cancer Research